You have 9 free searches left this month | for more free features.

sclc

Showing 1 - 25 of 720

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SCLC Trial in Changchun (PM8002, Paclitaxel)

Recruiting
  • SCLC
  • Changchun, China
    Jilin Provincial Tumor Hospital
May 25, 2023

Molecular Analysis and Treatment Options of SCLC

Recruiting
  • Small-cell Lung Cancer
  • +4 more
  • Shanghai, China
    Shanghai Chest Hospital
Jul 6, 2023

Nomogram Predicting Survival in Chinese SCLC Patients

Completed
  • Small Cell Lung Cancer
  • initial chemotherapy response
  • (no location specified)
Jan 8, 2023

SCLC,Extensive Stage Trial in Hangzhou (Thoracic radiotherapy)

Recruiting
  • SCLC,Extensive Stage
  • Thoracic radiotherapy
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 14, 2022

Small-cell Lung Cancer Trial in Guangzhou (Serplulimab)

Recruiting
  • Small-cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong Provincial Perople's Hospital
Jul 20, 2023

SCLC,Extensive Stage Trial in Omaha (RYZ101 Dose Level 1, RYZ101 Dose Level 2, RYZ101 Dose Level 3)

Recruiting
  • SCLC,Extensive Stage
  • RYZ101 Dose Level 1
  • +6 more
  • Omaha, Nebraska
    Nebraska Cancer Specialists
Nov 18, 2022

Small Cell Lung Cancer Extensive Stage Trial (quaratusugene ozeplasmid, atezolizumab)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • quaratusugene ozeplasmid
  • atezolizumab
  • (no location specified)
Jan 19, 2023

SCLC Trial (PM8002, Platinum, Atezolizumab)

Not yet recruiting
  • SCLC
  • (no location specified)
May 4, 2023

Safety and Efficacy of Zepzelca™ Injection

Recruiting
  • SCLC
    • Seoul, Korea, Republic of
      Seoul National University Boramae Medical Center
    Aug 28, 2023

    Small Cell Lung Cancer Trial (SC0245, Irinotecan)

    Not yet recruiting
    • Small Cell Lung Cancer
    • (no location specified)
    Feb 7, 2023

    Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • (no location specified)
    May 22, 2023

    RW Effectiveness of Lurbinectedin in Extensive Stage SCLC

    Completed
    • Small-cell Lung Cancer
    • Paris, France
    • +1 more
    Jan 5, 2023

    Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC

    Completed
    • Small Cell Lung Cancer
    • atezolizumab
    • Chalon-sur-Saône, France
    • +1 more
    Jan 5, 2023

    Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer Trial in Nashville (drug, biological, radiation, procedure)

    Not yet recruiting
    • Extensive Stage Lung Small Cell Carcinoma
    • Stage IV Lung Cancer
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Oct 25, 2023

    Small Cell Lung Cancer Trial in Saint Louis (AL8326 low dose group, AL8326 middle dose group, AL8326 high dose group)

    Recruiting
    • Small Cell Lung Cancer
    • AL8326 low dose group
    • +2 more
    • Saint Louis, Missouri
      Siteman cancer center, Washington University
    Nov 1, 2022

    SCLC, Extensive Stage Trial in Shanghai (AK112, Etoposide, Carboplatin)

    Recruiting
    • SCLC, Extensive Stage
    • Shanghai, Shanghai, China
      Shun Lu
    Oct 12, 2022

    Limited-stage Small Cell Lung Cancer (LS-SCLC) Trial in Jinan (Tifcemalimab injection, toripalimab injection, Placebo for

    Not yet recruiting
    • Limited-stage Small Cell Lung Cancer (LS-SCLC)
    • Tifcemalimab injection
    • +3 more
    • Jinan, Shandong, China
      Shandong Cancer Hospital & Institute
    Oct 18, 2023

    Molecular Subtyping of Extensive Stage Small Cell Lung Cancer

    Recruiting
    • SCLC,Extensive Stage
    • PD-(L)1 antibody immunotherapy
    • Beijing, Beijing, China
      Peking University Cancer Hospital & Institute
    Jul 3, 2023

    EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)

    Recruiting
    • EGFR-Mutated Non-Small-Cell Lung Carcinoma
    • Small Cell/Neuroendocrine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Small Cell Lung Cancer (SCLC) Trial in Guangzhou (Anlotinib Tislelizumab Irinotecan)

    Recruiting
    • Small Cell Lung Cancer (SCLC)
    • Anlotinib Tislelizumab Irinotecan
    • Guangzhou, Guangdong, China
      Guangdong Provincial Hospital of Traditional Chinese Medicine
    Jun 30, 2022

    Extensive Stage Small Cell Lung Cancer (ES-SCLC) Trial (HS-20093)

    Not yet recruiting
    • Extensive Stage Small Cell Lung Cancer (ES-SCLC)
    • (no location specified)
    Sep 19, 2023

    Extensive Stage Small Cell Lung Cancer Trial (HLX10 + chemo (carboplatin-etoposide), Atezolizumab + chemo

    Not yet recruiting
    • Extensive Stage Small Cell Lung Cancer
    • HLX10 + chemotherapy (carboplatin-etoposide)
    • Atezolizumab + chemotherapy (carboplatin-etoposide)
    • (no location specified)
    Jul 19, 2022

    Reveal Patterns of Presentation, Management and Outcome of SCLC

    Recruiting
    • Lung Cancer
      • Dammam, Saudi Arabia
      • +2 more
      Jul 25, 2022

      Treatment Patterns in Advanced Small Cell Lung Cancer (SCLC)

      Completed
      • Lung Cancer
        • Barcelona, Spain
        • +1 more
        Jan 11, 2022